CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $374 | -4.8% | 12,681 | +5.1% | 0.03% | -9.7% |
Q2 2023 | $393 | +2.9% | 12,062 | +11.2% | 0.03% | +10.7% |
Q1 2023 | $382 | -29.4% | 10,848 | -8.1% | 0.03% | -37.8% |
Q4 2022 | $541 | -99.9% | 11,806 | +35.1% | 0.04% | +15.4% |
Q3 2022 | $423,000 | -3.0% | 8,738 | -21.2% | 0.04% | 0.0% |
Q2 2022 | $436,000 | +65.8% | 11,086 | +55.0% | 0.04% | +333.3% |
Q1 2022 | $263,000 | +20.1% | 7,154 | +48.9% | 0.01% | +12.5% |
Q4 2021 | $219,000 | +4.8% | 4,804 | -17.7% | 0.01% | -11.1% |
Q3 2021 | $209,000 | – | 5,840 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |